1. Home
  2. NSPR vs OPTH Comparison

NSPR vs OPTH Comparison

Compare NSPR & OPTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InspireMD Inc.

NSPR

InspireMD Inc.

HOLD

Current Price

$0.72

Market Cap

33.7M

Sector

Health Care

ML Signal

HOLD

Logo Optimi Health Corp. Common Shares

OPTH

Optimi Health Corp. Common Shares

N/A

Current Price

$4.98

Market Cap

28.9M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
NSPR
OPTH
Founded
2005
N/A
Country
United States
Canada
Employees
N/A
9
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.7M
28.9M
IPO Year
2009
N/A

Fundamental Metrics

Financial Performance
Metric
NSPR
OPTH
Price
$0.72
$4.98
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
39.9K
46.7K
Earning Date
05-04-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,310,000.00
N/A
Revenue This Year
$57.98
N/A
Revenue Next Year
$95.41
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.63
$4.00
52 Week High
$2.59
$5.45

Technical Indicators

Market Signals
Indicator
NSPR
OPTH
Relative Strength Index (RSI) 51.86 62.56
Support Level $0.69 $4.13
Resistance Level $0.72 $5.45
Average True Range (ATR) 0.03 0.30
MACD 0.01 0.02
Stochastic Oscillator 89.14 100.00

Price Performance

Historical Comparison
NSPR
OPTH

About NSPR InspireMD Inc.

InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.

About OPTH Optimi Health Corp. Common Shares

Optimi Health Corp operates in developing a vertically integrated Canadian functional mushroom brand that focuses on the health and wellness sector. The company has one reportable operating segment being that of the farming, processing, and distribution of raw mushroom biomass. It also intends to cultivate, extract, process, and distribute strains of fungi products at its facilities located in Princeton, British Columbia.

Share on Social Networks: